2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid

C21H19BrClN5O3 — CID 174208985

IUPAC2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid
SMILESO=C(O)N1CCOC(Cn2ccc3cc(Cl)cc(-c4ncnn5cc(CBr)cc45)c32)C1
InChIInChI=1S/C21H19BrClN5O3/c22-8-13-5-18-19(24-12-25-28(18)9-13)17-7-15(23)6-14-1-2-26(20(14)17)10-16-11-27(21(29)30)3-4-31-16/h1-2,5-7,9,12,16H,3-4,8,10-11H2,(H,29,30)
InChIKeyYMYIVEOETPVMLF-UHFFFAOYSA-N
MW504.77 g/mol
LogP4.28
Rot. Bonds4

About 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid

2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid (PubChem CID 174208985) has the molecular formula C21H19BrClN5O3 and a molecular weight of 504.77 g/mol. Its IUPAC name is 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid.

Molecular Properties

Compound Name2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid
PubChem CID174208985
Molecular FormulaC21H19BrClN5O3
Molecular Weight504.77 g/mol
Exact Mass503.04
IUPAC Name2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid
SMILESO=C(O)N1CCOC(Cn2ccc3cc(Cl)cc(-c4ncnn5cc(CBr)cc45)c32)C1
InChIInChI=1S/C21H19BrClN5O3/c22-8-13-5-18-19(24-12-25-28(18)9-13)17-7-15(23)6-14-1-2-26(20(14)17)10-16-11-27(21(29)30)3-4-31-16/h1-2,5-7,9,12,16H,3-4,8,10-11H2,(H,29,30)
InChIKeyYMYIVEOETPVMLF-UHFFFAOYSA-N
XLogP4.28
TPSA84.89 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500504.77
LogP ≤ 54.28
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid?
The IUPAC name of 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid (CID 174208985) is 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid.
What is the SMILES notation for 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid?
The canonical SMILES for 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid is O=C(O)N1CCOC(Cn2ccc3cc(Cl)cc(-c4ncnn5cc(CBr)cc45)c32)C1.
What is the InChIKey of 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid?
The InChIKey is YMYIVEOETPVMLF-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H19BrClN5O3/c22-8-13-5-18-19(24-12-25-28(18)9-13)17-7-15(23)6-14-1-2-26(20(14)17)10-16-11-27(21(29)30)3-4-31-16/h1-2,5-7,9,12,16H,3-4,8,10-11H2,(H,29,30).
What are the key properties of 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid?
2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid has a molecular weight of 504.77 g/mol, XLogP of 4.28, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[7-[6-(bromomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-5-chloroindol-1-yl]methyl]morpholine-4-carboxylic acid is sourced from PubChem (CID 174208985), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).